Allison Coker, PhD
Clinical Research Analyst
Neurology
School of Medicine

Education & Training

Show all (2) Hide

• BS Neuroscience & Behavioral Biology Emory Univerisity
• PhD Neuroscience University of California, San Francisco

Publications (13)

Top publication keywords:
Ventral Tegmental AreaStress Disorders, Post-TraumaticChoice BehaviorCatechol O-Methyltransferase InhibitorsEnkephalin, D-Penicillamine (2,5)-Cross-Over StudiesDrug-Related Side Effects and Adverse ReactionsDouble-Blind MethodEthanolAlcoholismImpulsive BehaviorAlcohol DrinkingN-Methyl-3,4-methylenedioxyamphetamineHallucinogensReceptors, Opioid, delta

• Effects of MDMA-assisted therapy for PTSD on self-experience.
  PloS one 2024 van der Kolk BA, Wang JB, Yehuda R, Bedrosian L, Coker AR, Harrison C, Mithoefer M, Yazar-Klosinki B, Emerson A, Doblin R
• MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
  Focus (American Psychiatric Publishing) 2023 Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, Ot'alora G M, Garas W, Paleos C, Gorman I, Nicholas C, Mithoefer M, Carlin S, Poulter B, Mithoefer A, Quevedo S, …
• Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder.
  Frontiers in psychiatry 2023 Singleton SP, Wang JB, Mithoefer M, Hanlon C, George MS, Mithoefer A, Mithoefer O, Coker AR, Yazar-Klosinski B, Emerson A, Doblin R, Kuceyeski A
• Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.
  Neuropharmacology 2022 Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ
• The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD.
  Drug and alcohol dependence 2022 Nicholas CR, Wang JB, Coker A, Mitchell JM, Klaire SS, Yazar-Klosinski B, Emerson A, Brown RT, Doblin R

Show all (8 more) Hide

• Reply to: Caution at psychiatry's psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapy.
  Nature medicine 2021 Mitchell J, Coker A, Yazar-Klosinski B
• Scaling Up: Multisite Open-Label Clinical Trials of MDMA-Assisted Therapy for Severe Posttraumatic Stress Disorder
  Journal of Humanistic Psychology 2021 Wang JB, Lin J, Bedrosian L, Coker A, Jerome I, Feduccia A, Lilienstein A, Harrison C, Heimler E, Mithoefer M, Mithoefer A, Ot’alora G. M, Poulter B, Carlin S, Matthews R, Yazar-Klosinski B, Emerson A…
• MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
  Nature medicine 2021 Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, Ot'alora G M, Garas W, Paleos C, Gorman I, Nicholas C, Mithoefer M, Carlin S, Poulter B, Mithoefer A, Quevedo S, …
• The catechol-O-methyltransferase inhibitor tolcapone modulates alcohol consumption and impulsive choice in alcohol use disorder.
  Psychopharmacology 2020 Coker AR, Weinstein DN, Vega TA, Miller CS, Kayser AS, Mitchell JM
• Intra-VTA deltorphin, but not DPDPE, induces place preference in ethanol-drinking rats: distinct DOR-1 and DOR-2 mechanisms control ethanol consumption and reward.
  Alcoholism, clinical and experimental research 2013 Mitchell JM, Margolis EB, Coker AR, Allen DC, Fields HL
• Alcohol self-administration, anxiety, and cortisol levels predict changes in delta opioid receptor function in the ventral tegmental area.
  Behavioral neuroscience 2012 Mitchell JM, Margolis EB, Coker AR, Fields HL
• The anticonvulsant levetiracetam potentiates alcohol consumption in non-treatment seeking alcohol abusers.
  Journal of clinical psychopharmacology 2012 Mitchell JM, Grossman LE, Coker AR, Messing RO
• Reliability in the identification of midbrain dopamine neurons.
  PloS one 2010 Margolis EB, Coker AR, Driscoll JR, Lemaître AI, Fields HL